FR2068463B1 - - Google Patents

Info

Publication number
FR2068463B1
FR2068463B1 FR7028941A FR7028941A FR2068463B1 FR 2068463 B1 FR2068463 B1 FR 2068463B1 FR 7028941 A FR7028941 A FR 7028941A FR 7028941 A FR7028941 A FR 7028941A FR 2068463 B1 FR2068463 B1 FR 2068463B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7028941A
Other languages
French (fr)
Other versions
FR2068463A1 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of FR2068463A1 publication Critical patent/FR2068463A1/fr
Application granted granted Critical
Publication of FR2068463B1 publication Critical patent/FR2068463B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C07C39/20—Hydroxy-styrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
FR7028941A 1969-08-05 1970-08-05 Expired FR2068463B1 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1939809A DE1939809B2 (de) 1969-08-05 1969-08-05 ß-Aryl-2-aminoalkoxy-styrole und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
FR2068463A1 FR2068463A1 (ja) 1971-08-27
FR2068463B1 true FR2068463B1 (ja) 1974-08-30

Family

ID=5741970

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7028941A Expired FR2068463B1 (ja) 1969-08-05 1970-08-05

Country Status (25)

Country Link
JP (6) JPS4941433B1 (ja)
KR (1) KR780000113B1 (ja)
AT (5) AT303055B (ja)
BE (1) BE754405A (ja)
BG (6) BG17952A3 (ja)
CH (6) CH548368A (ja)
CS (6) CS170537B2 (ja)
DE (1) DE1939809B2 (ja)
DK (1) DK139717B (ja)
ES (6) ES382429A1 (ja)
FI (1) FI54912C (ja)
FR (1) FR2068463B1 (ja)
GB (1) GB1307436A (ja)
HU (1) HU163185B (ja)
IE (1) IE34634B1 (ja)
IL (1) IL35047A (ja)
NL (1) NL7011590A (ja)
NO (1) NO135243C (ja)
PH (1) PH9520A (ja)
PL (2) PL93130B1 (ja)
RO (5) RO58837A (ja)
SE (1) SE382211B (ja)
SU (4) SU428597A3 (ja)
YU (2) YU198170A (ja)
ZA (1) ZA705411B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50139537A (ja) * 1974-04-25 1975-11-07
US4220603A (en) * 1977-10-07 1980-09-02 Mitsubishi Chemical Industries, Limited Pharmaceutically active (omega-aminoalkoxy)bibenzyls
JPS6045632B2 (ja) * 1978-03-09 1985-10-11 三菱化学株式会社 ω−アミノアルコキシスチルベン類及びその酸付加塩
DE2818765A1 (de) 1978-04-28 1979-11-08 Basf Ag Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols
DE2818998A1 (de) * 1978-04-29 1979-11-15 Basf Ag 3-alkyl-5-(2-hydroxy-styryl)-isoxazole und verfahren zu ihrer herstellung
DE2818999A1 (de) * 1978-04-29 1979-11-15 Basf Ag Aminoderivate von 3-alkyl-5-(2- hydroxystyryl)-isoxazolen
JPS5629548A (en) * 1979-08-16 1981-03-24 Mitsubishi Chem Ind Ltd Omega-aminoalkoxystilbenes and their acid addition salts
DE2943406A1 (de) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Aminoderivate des 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols
DE2943405A1 (de) * 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Neue aminoderivate des 5-(2-hydroxystyryl)-isoxazols
DE3006809A1 (de) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2-((3-amino-2-hydroxy-propoxy)-styryl)-isoxazole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
JPS5874379U (ja) * 1981-11-16 1983-05-19 富士通株式会社 電子装置
NZ213986A (en) * 1984-10-30 1989-07-27 Usv Pharma Corp Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such
EP2717821B1 (en) 2011-06-10 2019-08-07 The Procter and Gamble Company Disposable diapers
WO2012170808A1 (en) 2011-06-10 2012-12-13 The Procter & Gamble Company Absorbent core for disposable absorbent articles
WO2012170779A1 (en) 2011-06-10 2012-12-13 The Procter & Gamble Company Absorbent structure for absorbent articles
EP2740449B1 (en) 2012-12-10 2019-01-23 The Procter & Gamble Company Absorbent article with high absorbent material content
EP2813201B1 (en) 2013-06-14 2017-11-01 The Procter and Gamble Company Absorbent article and absorbent core forming channels when wet
US9987176B2 (en) 2013-08-27 2018-06-05 The Procter & Gamble Company Absorbent articles with channels
EP3351225B1 (en) 2013-09-19 2021-12-29 The Procter & Gamble Company Absorbent cores having material free areas
PL2886092T3 (pl) 2013-12-19 2017-03-31 The Procter And Gamble Company Wkłady chłonne z obszarami tworzącymi kanały i zgrzewami osłony c

Also Published As

Publication number Publication date
ES382428A1 (es) 1972-11-16
GB1307436A (en) 1973-02-21
CH548367A (de) 1974-04-30
AT302344B (de) 1972-10-10
NO135243C (ja) 1977-03-09
PL93130B1 (ja) 1977-05-30
SE382211B (sv) 1976-01-19
AT301565B (de) 1972-09-11
JPS5113147B1 (ja) 1976-04-26
RO58861A2 (ro) 1975-06-30
YU37478A (en) 1979-07-10
ES382426A1 (es) 1972-11-16
RO57548A (ja) 1975-02-15
RO57794A (ja) 1975-06-15
KR780000113B1 (en) 1978-04-15
SU432712A3 (ja) 1974-06-15
CS170533B2 (ja) 1976-08-27
BG17952A3 (ja) 1974-03-05
BG17951A3 (ja) 1974-03-05
CH548366A (de) 1974-04-30
AT303055B (de) 1972-11-10
CH548368A (de) 1974-04-30
ES382429A1 (es) 1972-11-16
JPS4941433B1 (ja) 1974-11-08
PL78370B1 (ja) 1975-06-30
JPS5113146B1 (ja) 1976-04-26
YU198170A (en) 1979-07-10
FI54912B (fi) 1978-12-29
CS170536B2 (ja) 1976-08-27
ES382425A1 (es) 1972-11-16
IE34634B1 (en) 1975-07-09
DK139717C (ja) 1979-09-17
IL35047A (en) 1973-05-31
AT302346B (de) 1972-10-10
NO135243B (ja) 1976-11-29
BG18600A3 (ja) 1975-02-25
AT302345B (de) 1972-10-10
JPS5113149B1 (ja) 1976-04-26
SU439966A3 (ru) 1974-08-15
PH9520A (en) 1976-01-09
BG20095A3 (ja) 1975-10-30
CS170538B2 (ja) 1976-08-27
IL35047A0 (en) 1970-10-30
DE1939809B2 (de) 1978-04-13
NL7011590A (ja) 1971-02-09
FR2068463A1 (ja) 1971-08-27
ES382427A1 (es) 1972-11-16
SU439965A3 (ru) 1974-08-15
CH548983A (de) 1974-05-15
IE34634L (en) 1971-02-05
DE1939809C3 (ja) 1979-01-11
BG18599A3 (ja) 1975-02-25
JPS5113150B1 (ja) 1976-04-26
ES382430A1 (es) 1972-12-01
CS170535B2 (ja) 1976-08-27
SU428597A3 (ru) 1974-05-15
HU163185B (ja) 1973-06-28
CH548981A (de) 1974-05-15
BE754405A (fr) 1971-02-04
FI54912C (fi) 1979-04-10
DE1939809A1 (de) 1971-02-18
DK139717B (da) 1979-04-02
ZA705411B (en) 1971-05-27
CS170537B2 (ja) 1976-08-27
RO58837A (ja) 1975-09-15
RO57793A (ja) 1975-03-15
JPS5113148B1 (ja) 1976-04-26
SU450398A3 (ru) 1974-11-15
CS170534B2 (ja) 1976-08-27
BG17950A3 (ja) 1974-03-05
CH548982A (de) 1974-05-15

Similar Documents

Publication Publication Date Title
FR2068463B1 (ja)
AU465413B2 (ja)
AU450150B2 (ja)
AU2355770A (ja)
AU442375B2 (ja)
AU470301B1 (ja)
AU442538B2 (ja)
AU442463B2 (ja)
AU442285B2 (ja)
AU442322B2 (ja)
AU442357B2 (ja)
AU470661B1 (ja)
AU442554B2 (ja)
AU442380B2 (ja)
AU442535B2 (ja)
AU4540468A (ja)
AU4949169A (ja)
AU4953367A (ja)
AU4982068A (ja)
AU4815038A (ja)
AU5006968A (ja)
AU5066368A (ja)
AU448562A (ja)
AU481328A (ja)
AU3858369A (ja)

Legal Events

Date Code Title Description
ST Notification of lapse